| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MCGUIRK TERENCE F | Chairman, President & CEO, Director, 10%+ Owner | C/O ATLANTA BRAVES HOLDINGS, INC., 755 BATTERY AVENUE SE, ATLANTA | /s/ Kerry T. Wenzel, Attorney-in-Fact | 15 Dec 2025 | 0001232631 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BATRK | Series C Common Stock | Options Exercise | $0 | +15K | +6.26% | $0.00 | 255K | 11 Dec 2025 | Direct | F1 |
| transaction | BATRK | Series C Common Stock | Sale | -$266K | -6.69K | -2.62% | $39.72 | 249K | 12 Dec 2025 | Direct | F2, F3 |
| holding | BATRK | Series C Common Stock | 265K | 11 Dec 2025 | By Trust | F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BATRK | Restricted Stock Units - BATRK | Options Exercise | $0 | -15K | -50% | $0.00 | 15K | 11 Dec 2025 | Series C Common Stock | 15K | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit converted into one share of Series C Common Stock. |
| F2 | The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units. |
| F3 | Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| F4 | Reflects shares held in a family trust for which the reporting person's spouse is trustee and the reporting person's children are beneficiaries. |
| F5 | Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock. |
| F6 | One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026. |